We’re successfully offering a new minimally invasive, single-incision procedure to patients who need surgery to address both mitral valve disease and hypertrophic obstructive cardiomyopathy.
When Hypertrophic Obstructive Cardiomyopathy Presents with Barlow’s Valve: A Case Study in Myectomy
Concurrent HOCM and Barlow’s valve can prove vexing, as standard therapy for one is counterproductive to the other. We share a case study with lessons for overcoming this clinical challenge.
Sudden Death Risk in Obstructive HCM: Time to Refine the Criteria?
A large retrospective study suggests that factoring myectomy and atrial fibrillation into risk scores for sudden cardiac death significantly reclassifies risk in patients with hypertrophic cardiomyopathy.
LV Strain May Offer Independent Prognostic Utility in Obstructive Hypertrophic Cardiomyopathy
A large retrospective study suggests that left ventricular global longitudinal strain measurement can help identify at-risk patients with obstructive HCM who may benefit from earlier myectomy.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy